- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04990986
Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes (SAME)
Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes - A Mixed Methods Study Embedding a Cluster Randomised Controlled Trial, Guided by Safety Theory With Participatory Approach
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the SAME-study, we aim to develop and evaluate a new, multifaceted (complex) intervention in a mixed methods study-design to increase medication safety in nursing homes. The SAME-study will be locally anchored, including investigation of patient safety culture, in a mixed methods design, including both in depth qualitative and organizational-focused quantitative methods. This study will be guided by the following main research questions and hypothesis:
- Can we elucidate new areas susceptible for intervention to increase medication safety in nursing homes through qualitative in-depth investigation of patient safety culture in nursing homes guided by safety theory with participatory approach?
- Is it possible to develop a multifaceted intervention fit to context within actual resource-frame to increase medication safety in nursing homes based on patient safety culture, guided by safety theory with participatory approach?
- A complex intervention developed within a participatory framework will lead to positive change of care-staff self-reported perceptions of patient safety climate culture in nursing homes in the intervention group compared with the control group of this study?
Study design This study applies mixed-methods pragmatic paradigm led by Safety 1 and 2 theory, with participatory approach to an exploratory sequential three-phased study-design, embedding a randomized controlled trial (cRCT). Overall study-settings will be nursing homes within the municipality of Aalborg, North Denmark Region, Denmark.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anne E Olesen, Ph.D.
- Phone Number: +4597664376
- Email: aneso@rn.dk
Study Contact Backup
- Name: Marie Juhl, MD
- Phone Number: +4597664376
- Email: marie.juhl@rn.dk
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Recruiting
- Aalborg University Hospital
-
Contact:
- Anne E Olesen, Ph.D
- Phone Number: +4597664376
- Email: aneso@rn.dk
-
Contact:
- Marie H Juhl, MD
- Phone Number: +4597664376
- Email: marie.juhl@rn.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- involved directly or indirectly in the medication process
- employment of at least two months in a nursing-home within the municipality of Aalborg, sufficient spoken and written Danish language
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention
The complex intervention will be co-developed during first phase of the study.
|
Will be co-developed during the study.
|
No Intervention: Control
Half of the group will be included as control and thus not exposed to the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Care staff's perceptions of patient safety culture
Time Frame: One year
|
Safety Attitudes Questionnaire (SAQ)
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceptions of patient safety culture of relatives of residents and nursing home doctors.
Time Frame: One year
|
Qualitative data will be collected through individual interviews with relatives and GPs
|
One year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety assessments
Time Frame: One year
|
data from medical records and national registers will be used for safety assessments.
|
One year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Anne E Olesen, Ph.D., Aalborg University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AalborgH2021-015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Safety
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminatedPatient Empowerment | Patient Safety | Medication SafetyNetherlands
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoNot yet recruiting
-
University Health Network, TorontoSunnybrook Health Sciences Centre; Sinai Health SystemCompleted
-
Johannes Gutenberg University MainzCompleted
-
Fundació d'investigació Sanitària de les Illes...Ministerio de Economía y Competitividad, SpainUnknown
-
Ottawa Hospital Research InstituteCompleted
-
Charite University, Berlin, GermanyCompleted
-
Fundació d'investigació Sanitària de les Illes...Andalusian School of Public Health; Fundación Avedis Donabedian; IDIAP JORDI GOL and other collaboratorsNot yet recruiting
-
NHS Education for ScotlandRecruitingPatient SafetyUnited Kingdom
-
University of California, San FranciscoCompleted
Clinical Trials on Complex intervention
-
Pakistan Institute of Living and LearningUniversity of Manchester; Dow University of Health SciencesCompletedDepression, Postpartum | Postnatal DepressionPakistan
-
Oslo University HospitalUniversity of Oslo; Norwegian University of Science and Technology; University... and other collaboratorsActive, not recruiting
-
Goethe UniversityMaastricht University Medical Center; German Federal Ministry of Education... and other collaboratorsCompleted
-
Seton Healthcare FamilyUniversity of Texas at AustinCompletedQuality of Life | Chronic Disease | Chronic IllnessUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Cardiovascular Disease RiskUnited States
-
Murdoch Childrens Research InstituteLa Trobe UniversityCompleted
-
Heinrich-Heine University, DuesseldorfUniversity Hospital, Essen; University Hospital Muenster; University of Cologne; University Hospital, Bonn and other collaboratorsRecruiting
-
Odense University HospitalUniversity of Southern DenmarkCompletedStroke | Transient Ischemic AttackDenmark
-
Oslo University HospitalUniversity of Oslo; Norwegian University of Science and Technology; University... and other collaboratorsCompleted
-
Mayo ClinicMinnesota Department of Health; Altru Health System; Iowa Department of Public... and other collaboratorsCompletedTraumatic Brain InjuryUnited States